Evan Wu, MD

Dr. Wu is a double-fellowship trained, board-certified medical oncologist and researcher at Hoag Family Cancer Institute. His practice focuses on thoracic cancers, including lung cancer and mesothelioma.

Through his involvement in cancer research, Dr. Wu focuses on identifying new therapies to improve the lives of patients with thoracic cancers through clinical trials at Hoag. As an active member of the medical oncology community, Dr. Wu has led the development of several clinical trials concentrated on lung cancer, mesothelioma, cellular therapy for HPV-associated cancers, head and neck cancer, pharmaceuticals and artificial intelligence and continues to lead and monitor developing research.

Dr. Wu attended Johns Hopkins School of Medicine, Division of Hematology and Oncology, where he was double-fellowship trained in medical oncology and medical oncology research. He also earned a Doctorate of Philosophy in clinical trials investigation at Johns Hopkins School of Public Health and School of Medicine. He completed his medical degree at University of Miami and went on to complete his internal medicine residency at Baylor College of Medicine in Houston, Texas. He earned his master’s degree from University of Pennsylvania, Perelman School of Medicine and his undergraduate degree at the University of California, Berkeley.

His interests outside of medicine include tennis, hiking and exercising his two Jack Russell Terriers.